SecBot SecBot
SC 13G/A ·Filed Nov 13, 2026

MDWD

MediWound Ltd.
NEUTRAL
Impact 3/10
Horizonweeks Processed3d 16h ago SEC0001622627-26-000029
Passive stake amendment
Actionable Insight • Neutral

Monitor whether Rosalind Advisors files a Schedule 13D (activist intent) or continues to increase its position. The 9.1% stake is below the 10% threshold that would require more detailed disclosure, but any further accumulation or change in filing status would signal a shift in strategy.

DirectionNeutral
Confidencemedium
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$12.90
T+0 close · Nov 13, 2026 · via day close
Latest settled
+5.04%
T+1 · $13.55
Vs SPY
+6.95%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $12.90entry
  2. T+1 · 20h ago +5.04%α +6.95% · $13.55
  3. T+5 · in 3d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Rosalind Advisors and related entities filed an amended Schedule 13G disclosing beneficial ownership of 1,312,319 shares (9.1% of outstanding common stock) of MediWound Ltd., consisting of 1,149,054 common shares and 163,265 shares issuable upon exercise of warrants. The filing updates a prior 13G from May 2026, but no prior stake figures are available in the provided documents for comparison; the stake appears to be a new position or an increase from a previously unreported level.

Key Financial Metrics

Stake
9.1%
Investor
Rosalind Advisors, Inc.
Investor Type
hedge fund

Key Facts

  • Rosalind Advisors, Inc., Rosalind Master Fund L.P., Steven Salamon, and Gilad Aharon jointly filed an amended Schedule 13G on November 13, 2026.
  • The group reports beneficial ownership of 1,312,319 shares, representing 9.1% of MediWound's 14,210,217 common shares outstanding as of November 5, 2026.
  • The stake comprises 1,149,054 common shares and 163,265 shares issuable upon exercise of warrants (subject to a 9.99% blocker provision).
  • The filing is an amendment to a prior Schedule 13G filed on May 15, 2026; no prior stake percentage or share count is provided in the current documents for comparison.
  • The filers certify passive intent under Rule 13d-1(d), disclaiming any purpose to change or influence control.

Financial Impact

9.1% beneficial ownership stake valued at approximately $18.1M based on $199M market cap

ownershipdilution

Risk Factors

  • The filing does not provide prior stake data for comparison, so the direction of change (increase, decrease, or new position) cannot be determined from the documents alone.
  • The 163,265 warrant shares are subject to a blocker provision limiting exercise to 9.99% beneficial ownership, capping potential dilution impact.
  • As a passive 13G filer, Rosalind Advisors disclaims activist intent, but any future conversion to a 13D would indicate a more active stance.

Market Snapshot

Exchange
Nasdaq
Sector
Medicinal Chemicals & Botanical Products
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001622627-26-000029
Document: 0001622627-26-000029-index-headers.html0001622627-26-000029
Document: 0001622627-26-000029-index.html0001622627-26-000029
Document: 0001622627-26-000029.txt0001622627-26-000029

Track record

13 reports on MDWD

Performance horizon

6 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +20.80% at T+60 after the Mar 5, 2026 report. 7 of 8 went positive at some point.

Filters
  1. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Viewing Entry $12.90 Now $13.55 +5.04% settles Nov 20
  2. Nov 12, 20264d ago 6-K Bearish 6/10 No price data
  3. Nov 12, 20264d ago Press Release Bearish 6/10 Entry $12.97 Now $13.55 −4.47% settles Nov 19
  4. Nov 5, 202611d ago 6-K Bearish 6/10 Entry $13.33 to $12.97 Now $13.55 −1.65% ▲ +2.70% +5.99% vs SPY
  5. Nov 5, 202611d ago 424B5 Bearish 5/10 Entry $13.33 to $12.97 Now $13.55 −1.65% ▲ +2.70% +5.99% vs SPY
  6. Nov 3, 202613d ago 424B5 Bearish 5/10 Entry $14.20 to $13.82 Now $13.55 +4.58% ▲ +2.68% +1.76% vs SPY
  7. Sep 22, 20267w ago Press Release Bullish 4/10 Entry $13.95 to $13.80 Now $13.55 −2.87% ▼ −1.08% +0.11% vs SPY
  8. Jun 2, 202623w ago Insider Cluster Bullish 4/10 Entry $13.76 to $14.30 Now $13.55 −1.53% ▲ +3.92% +6.89% vs SPY
  9. May 27, 202624w ago Press Release Bearish 5/10 Entry $14.33 to $13.73 Now $13.55 +5.44% ▲ +4.19% +4.66% vs SPY
  10. May 7, 202627w ago Press Release Neutral 1/10 Entry $17.27 to $16.25 Now $13.55 −21.54% ▼ −5.91% −7.41% vs SPY
Showing 10 of 13

US Market Status

Market Closed · Opens in 6h 13m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026